Literature DB >> 8494386

Curative and preventive anticryptosporidium activities of sinefungin in an immunosuppressed adult rat model.

P Brasseur1, D Lemeteil, J J Ballet.   

Abstract

An immunosuppressed rat model was used to investigate the anti-Cryptosporidium parvum activity of sinefungin. In infected animals, oral sinefungin therapy resulted in a dose-related suppression of oocyst shedding, which correlated with oocyst disappearance from ileal sections. When administered prior to or on the day of oocyst challenge, sinefungin successfully prevented infection. These data suggest that sinefungin could be considered as a candidate molecule in the treatment of human cryptosporidiosis, considered to be the most significant enteric opportunistic infection in AIDS.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8494386      PMCID: PMC187800          DOI: 10.1128/AAC.37.4.889

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  23 in total

1.  Anticryptosporidial activity of sulfadimethoxine.

Authors:  J E Rekg; M L Hancock; D B Woodmansee
Journal:  Antimicrob Agents Chemother       Date:  1988-12       Impact factor: 5.191

2.  [Cryptosporidiosis in immunocompetent children].

Authors:  P Brasseur; D Lemeteil; E Mallet
Journal:  Presse Med       Date:  1987-02-07       Impact factor: 1.228

3.  Chemotherapeutic effect of arprinocid in experimental cryptosporidiosis.

Authors:  C W Kim
Journal:  J Parasitol       Date:  1987-06       Impact factor: 1.276

4.  Amoebicidal activity of the antifungal antibiotic sinefungin against Entamoeba histolytica.

Authors:  A Ferrante; I Ljungström; G Huldt; E Lederer
Journal:  Trans R Soc Trop Med Hyg       Date:  1984       Impact factor: 2.184

5.  [A simple technic for the demonstration of cryptosporidia in feces].

Authors:  J Heine
Journal:  Zentralbl Veterinarmed B       Date:  1982-05

6.  Inhibitory activity of sinefungin and SIBA (5'-deoxy-5'-S-isobutylthio-adenosine) on the growth of promastigotes and amastigotes of different species of Leishmania.

Authors:  U Bachrach; L F Schnur; J El-On; C L Greenblatt; E Pearlman; M Robert-Gero; E Lederer
Journal:  FEBS Lett       Date:  1980-12-01       Impact factor: 4.124

7.  Antitrypanosomal activity of sinefungin.

Authors:  D K Dube; G Mpimbaza; A C Allison; E Lederer; L Rovis
Journal:  Am J Trop Med Hyg       Date:  1983-01       Impact factor: 2.345

8.  Cryptosporidiosis of man and calf: a case report and results of experimental infections in mice and rats.

Authors:  N C Reese; W L Current; J V Ernst; W S Bailey
Journal:  Am J Trop Med Hyg       Date:  1982-03       Impact factor: 2.345

9.  Antitoxoplasmosis properties of sinefungin in mice.

Authors:  A Ferrante; I Ljungström; E Lederer
Journal:  C R Acad Sci III       Date:  1988

10.  Rat model for human cryptosporidiosis.

Authors:  P Brasseur; D Lemeteil; J J Ballet
Journal:  J Clin Microbiol       Date:  1988-05       Impact factor: 5.948

View more
  7 in total

1.  Evaluation of curative anticryptosporidial activity of paromomycin in a dexamethasone-treated rat model.

Authors:  R Verdon; J Polianski; C Gaudebout; C Marche; L Garry; J J Pocidalo
Journal:  Antimicrob Agents Chemother       Date:  1994-07       Impact factor: 5.191

2.  Synthesis and evaluation of dinitroanilines for treatment of cryptosporidiosis.

Authors:  J W Benbow; E L Bernberg; A Korda; J R Mead
Journal:  Antimicrob Agents Chemother       Date:  1998-02       Impact factor: 5.191

3.  Putative anticryptosporidial agents tested with an immunodeficient mouse model.

Authors:  G J Leitch; Q He
Journal:  Antimicrob Agents Chemother       Date:  1994-04       Impact factor: 5.191

4.  Bovine antibody against Cryptosporidium parvum elicits a circumsporozoite precipitate-like reaction and has immunotherapeutic effect against persistent cryptosporidiosis in SCID mice.

Authors:  M W Riggs; V A Cama; H L Leary; C R Sterling
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

5.  Evaluation of high-dose regimen of paromomycin against cryptosporidiosis in the dexamethasone-treated rat model.

Authors:  R Verdon; J Polianski; C Gaudebout; C Marche; L Garry; C Carbon; J J Pocidalo
Journal:  Antimicrob Agents Chemother       Date:  1995-09       Impact factor: 5.191

6.  Sinefungin resistance of Saccharomyces cerevisiae arising from Sam3 mutations that inactivate the AdoMet transporter or from increased expression of AdoMet synthase plus mRNA cap guanine-N7 methyltransferase.

Authors:  Sushuang Zheng; Stewart Shuman; Beate Schwer
Journal:  Nucleic Acids Res       Date:  2007-10-11       Impact factor: 16.971

7.  Characterization of copper(II) interactions with sinefungin, a nucleoside antibiotic: combined potentiometric, spectroscopic and DFT studies.

Authors:  Maria Jaworska; Piotr Lodowski; Ariel Mucha; Wojciech Szczepanik; Gianni Valensin; Massimo Cappannelli; Małgorzata Jezowska-Bojczuk
Journal:  Bioinorg Chem Appl       Date:  2007       Impact factor: 7.778

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.